[Transitory remission of hypercorticism by means of cyproheptadine in a patient with Cushing syndrome].
In patients with Cushing's syndrome of hypothalamischem Cushing-Syndrom wereden eine zentrale Störung und eine wichtige Rolle des Serotonins.  Accordingly, in the present study a patient with hypothalamic-pituitary hypercorticism was treated with the seotonin antagonist cyproheptadine. Urinary free cortisol excretion was measured repeatedly before, during and after therapy. In addition, night-day rhythm of plasma cortisol was determined before and at the end of cyproheptadine medication. Within 2 months, therapy with 24 mg cyproheptadine resulted in a lowering of urinary cortisol excretion to normal values. Then, however, despite continuation of the therapy, urinary free cortisol excretion rates again rose to pathological levels. Due to the occurrence of severe psychosis, the drug had to be withdrawn. Before and under cyproheptadine no night-day rhythm of plasma cortisol could be observed.
D000315:Adrenalectomy; D000308:Adrenocortical Hyperfunction / Q000188:drug therapy*; D003480:Cushing Syndrome / Q000188:drug therapy*; D003533:Cyproheptadine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood / Q000652:urine; D011605:Psychoses, Substance-Induced / Q000209:etiology
D003533:Cyproheptadine; D006854:Hydrocortisone
Nicht dauerhaft Remission des Hyperkortizismus durch Cyproheptadin bei einer Patientin mit Cushing-Syndrom